President Droupadi Murmu on Thursday launched India’s first home-grown gene therapy for cancer at IIT Bombay.
Describing the newly-launched treatment, named “CAR-T cell therapy,” as a beacon of hope, President Murmu expressed confidence that the therapy will provide a new lease of life to countless cancer patients.
CAR-T cell therapy, considered a groundbreaking advancement in medical science, has long been available in developed nations. However, its prohibitive costs have rendered it beyond the reach of many.
President Murmu said that the therapy is not only accessible but also the world’s most affordable CAR-T cell therapy.
She applauded the collaborative efforts between the Indian Institute of Technology, Bombay, Tata Memorial Hospital, and industry partner ImmunoACT, highlighting the indigenous therapy as an example of the ‘Make in India’ and ‘Atmanirbhar Bharat’ initiatives.
